Form 4: Accuray Inc. Director Beverly A. Huss Acquires Restricted Stock Units

Director Beverly A. Huss acquired 56,603 restricted stock units of Accuray Inc., vesting in 2025.

Summary

• Beverly A. Huss, a director at Accuray Inc., acquired 56,603 restricted stock units (RSUs) on November 29, 2024.
• Each RSU represents the right to receive one share of Accuray's common stock.
• The RSUs will vest 100% on November 21, 2025.
• The transaction was reported on December 3, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction of stock-based compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of restricted stock units by a director may indicate confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units on November 21, 2025, is a future event that will result in the issuance of common stock to the director.

Industry Context

This is a standard practice for companies to grant stock-based compensation to directors and executives as part of their overall compensation package. It aligns the interests of the directors with those of the shareholders.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across publicly traded companies, including those in the medical technology sector like Accuray.
• Companies such as Varian Medical Systems and Elekta also use similar equity-based compensation methods to incentivize their directors and executives.
• The vesting period of approximately one year is also typical for such grants.

Stakeholder Impact

• The acquisition of restricted stock units by a director may be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Accuray Inc, Restricted Stock Units, RSU, Director, Beverly A. Huss, Stock Acquisition, Insider Trading, Equity Compensation